Evidence map›Paper›PMID 34268209›Full record

ArticleIranian journal of public health2020

"Five-Early" Model: The Magic Weapon against COVID-19.

Qingjie Yi, Wei Fang, Chunhui Lang, Huaming Mou, Jinglong Lv, Suxin Wan, Lian Guo, Yilin Wang, Huawen Liu, Qing Xiao and 3 more

Open access · goldAbstract read
In one paragraph

Article in Iranian journal of public health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 56% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Qingjie YiChongqing University Three Gorges Hospital, Chongqing 404100, China.
Wei FangChongqing University Three Gorges Hospital, Chongqing 404100, China.
Chunhui LangChongqing University Three Gorges Hospital, Chongqing 404100, China.
Huaming MouChongqing University Three Gorges Hospital, Chongqing 404100, China.
Jinglong LvChongqing University Three Gorges Hospital, Chongqing 404100, China.
Suxin WanChongqing University Three Gorges Hospital, Chongqing 404100, China.
Lian GuoChongqing University Three Gorges Hospital, Chongqing 404100, China.
Yilin WangChongqing University Three Gorges Hospital, Chongqing 404100, China.
Huawen LiuChongqing University Three Gorges Hospital, Chongqing 404100, China.
Qing XiaoDepartment of Hematology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
Chunqiu LiuChongqing University Three Gorges Hospital, Chongqing 404100, China.
Min HuangChongqing University Three Gorges Hospital, Chongqing 404100, China.
Bangshuo ZhangChongqing University Three Gorges Hospital, Chongqing 404100, China.
Chongqing University · CNChongqing Three Gorges Central Hospital · CNChongqing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCOVID-19(2019 novel coronavirus disease)has brought tremendous pressure to the prevention and control of the national epidemic due to its concealed onset, strong infectivity and fast transmission speed.

methodsIn this retrospective study, 226 patients diagnosed with 2019 novel coronavirus pneumonia (NCP) in the Chongqing University Three Gorges Hospital were included. The patients' clinical data, including general information, initial symptoms at the onset, time of disease diagnosis, time to treatment in hospital, time of nucleic acid conversion to negative, disease classification, total time of hospitalization were collected. The clinical data of the mild and severe patients were compared.

resultsFever, cough, sore throat, poor appetite andfatigue were the main symptoms of the diagnosed patients. The time of diagnosis was significantly shorter in the mild patients (4.96 ± 4.10 days) than severe patients (7.63 ± 9.17 days) (P=0.004). Mild patients had shorter time to treatment in hospital (6.09 ± 4.47 vs. 8.71 ± 9.04 days) and less time of nucleic acid conversion to negative (7.58 ± 2.51 vs. 11.6 ± 4.67 days) compared to the severe patients.

conclusionThe above results can be used as a quantitative basis for the "five-early"(early detection, early screening, early diagnosis, early isolation treatment, and early recovery) model. The government, the masses, and the hospitals' joint prevention and optimization of the "five-early" model will provide important scientific reference for further prevention and control of the epidemics.

Indexed as

COVID-19Current situation“Five-early” modelInvestigation

Identifiers

PMID34268209
PMCPMC8266013
OpenAlexW3029511604

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.